Arkadios Wealth Advisors Has $1.30 Million Stake in GE HealthCare Technologies Inc. $GEHC

Arkadios Wealth Advisors raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 43.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,608 shares of the company’s stock after purchasing an additional 5,329 shares during the quarter. Arkadios Wealth Advisors’ holdings in GE HealthCare Technologies were worth $1,304,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of GEHC. JPMorgan Chase & Co. raised its stake in shares of GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the period. Nuveen LLC acquired a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at about $77,058,000. Eminence Capital LP raised its stake in shares of GE HealthCare Technologies by 38.7% in the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock valued at $146,822,000 after purchasing an additional 507,101 shares during the period. Homestead Advisers Corp raised its stake in shares of GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock valued at $79,790,000 after purchasing an additional 475,500 shares during the period. Finally, Canada Pension Plan Investment Board raised its stake in shares of GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after purchasing an additional 409,636 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of recent research reports. Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their target price for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research report on Thursday. Barclays initiated coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price on the stock. Finally, BTIG Research set a $87.00 target price on GE HealthCare Technologies in a research report on Wednesday. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $86.10.

GE HealthCare Technologies Trading Down 0.1%

GE HealthCare Technologies stock opened at $74.95 on Friday. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.93 and a current ratio of 1.18. The stock has a market capitalization of $34.14 billion, a P/E ratio of 15.49, a PEG ratio of 2.84 and a beta of 1.13. The stock has a 50-day simple moving average of $75.09 and a 200 day simple moving average of $73.06.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same quarter last year, the company posted $1.14 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s payout ratio is currently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.